Simplex Trading’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$125K Buy
32,600
+2,300
+8% +$9.43K ﹤0.01% 4820
2025
Q4
$112K Buy
30,300
+28,800
+1,920% +$247K ﹤0.01% 4879
2025
Q3
$21K Sell
1,500
-19,600
-93% -$306K ﹤0.01% 7293
2025
Q2
$405K Sell
21,100
-44,100
-68% -$688K ﹤0.01% 3738
2025
Q1
$721K Buy
65,200
+64,600
+10,767% +$770K ﹤0.01% 3014
2024
Q4
$9K Sell
600
-927
-61% -$11.6K ﹤0.01% 7274
2024
Q3
$15K Buy
1,527
+127
+9% +$3.78K ﹤0.01% 6902
2024
Q2
$80K Buy
1,400
+153
+12% +$7.5K ﹤0.01% 5605
2024
Q1
$41K Sell
1,247
-5,200
-81% -$263K ﹤0.01% 6441
2023
Q4
$523K Buy
+6,447
New +$525K ﹤0.01% 3655
2023
Q3
Sell
-47
Closed -$15K 9494
2023
Q2
$15K Buy
+47
New +$14.3K ﹤0.01% 7044
2023
Q1
Sell
-13
Closed -$5K 9817
2022
Q4
$5K Hold
13
﹤0.01% 8079
2022
Q3
$3K Sell
13
-7
-35% -$1.87K ﹤0.01% 9126
2022
Q2
$4K Sell
20
-313
-94% -$135K ﹤0.01% 9005
2022
Q1
$227K Hold
333
﹤0.01% 4971
2021
Q4
$230K Buy
+333
New +$246K ﹤0.01% 4984

Other funds holding OM

Simplex Trading's OM Position: Q1 2026 in Review

Simplex Trading increased its Outset Medical (OM) stake by 17% in Q1 2026, buying an estimated $4.07K and bringing the position to 7,017 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6498.

Simplex Trading first reported a position in OM in Q1 2022 and has held it in 11 quarters since. The position peaked at $291K in Q2 2024. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Simplex Trading held 7,017 shares of Outset Medical worth $26.9K as of Q1 2026.
  • Simplex Trading bought 994 Outset Medical shares in Q1 2026, an estimated $4.07K.
  • Outset Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6498 holding.
  • Simplex Trading first reported a position in Outset Medical in Q1 2022 and has held it in 11 quarters since.
  • Simplex Trading's Outset Medical position peaked at $291K in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.